Back to search results

Basket Study for Oligo-metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

HER2-positive Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Antoni van Leeuwenhoek, Amsterdam, Netherlands

    Contact: Study coordinator (Robbert-Jan Gielen, MD)
    Contact: Study coordinator (Ingrid Mandjes, MSc)
    Contact: Principal Investigator (Marleen Kok, MD)
Study leads

  • Marleen Kok, MD

    Principal Investigator

    Antoni van Leeuwenhoek

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)